References
- Abhinaya, N. (2015). Hyperglycemia in type II diabetic patients: An overview. Research & Reviews: Journal of Medical and Health Sciences, 6, 7.
- Ali, H., Houghton, P. J., & Soumyanath, A. (2006). Alpha-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. Journal of Ethnopharmacology, 107(3), 449–455. https://doi.org/https://doi.org/10.1016/j.jep.2006.04.004
- Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins: Structure, Function, and Genetics, 17(4), 412–425. https://doi.org/https://doi.org/10.1002/prot.340170408
- Ansari, P., Afroz, N., Jalil, S., Azad, S. B., Mustakim, M. G., & Anwar, S. (2017). Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, alpha-amylase inhibition, and retardation of glucose absorption. Journal of Pediatric Endocrinology and Metabolism, 30(1), 37–47.
- Brayer, G. D., Sidhu, G., Maurus, R., Rydberg, E. H., Braun, C., Wang, Y., Nguyen, N. T., Overall, C. M., & Withers, S. G. (2000). Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques. Biochemistry, 39(16), 4778–4791. https://doi.org/https://doi.org/10.1021/bi9921182
- De Luca, C., & Olefsky, J. M. (2008). Inflammation and insulin resistance. FEBS Letters, 582(1), 97–105. https://doi.org/https://doi.org/10.1016/j.febslet.2007.11.057
- DeLano, W. (2002). The PyMOL molecular graphics system. CCP4 Newsletter on Protein Crystallography, 40, 82–92.
- Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991). The energy landscapes and motions of proteins. Science (New York, N.Y.), 254(5038), 1598–1603. https://doi.org/https://doi.org/10.1126/science.1749933
- Funke, I., & Melzig, M. F. (2006). Traditionally used plants in diabetes therapy-phytotherapeutics as inhibitors of α-amylase activity. Revista Brasileira de Farmacognosia, 16(1), 1–5. https://doi.org/https://doi.org/10.1590/S0102-695X2006000100002
- Guengerich, F. (2003). Cytochromes P450, drugs, and diseases. Molecular Interventions, 3(4), 194–204. https://doi.org/https://doi.org/10.1124/mi.3.4.194
- Hanefeld, M., & Schaper, F. (2008). Acarbose: Oral anti-diabetes drug with additional cardiovascular benefits. Expert Review of Cardiovascular Therapy, 6(2), 153–163. https://doi.org/https://doi.org/10.1586/14779072.6.2.153
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38, 27–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Ishnava, K. B., & Motisariya, D. M. (2018). In-vitro study on α-amylase inhibitory activity of selected ethnobotanical plant extracts and its herbal formulations. International Journal of Pharmacognosy and Chinese Medicine, 2(3), 136.
- Khulan, T., Ambaga, M., & Chimedragcha, C. (2015). Effect of honey bee venom (Apis mellifera) on hyperglycemia and hyperlipidemia in alloxan induced diabetic rabbits. Journal of Diabetes and Metabolism, 6, 507.
- Kotowaroo, M. I., Mahomoodally, M. F., Gurib-Fakim, A., & Subratty, A. H. (2006). Screening of traditional antidiabetic medicinal plants of Mauritius for possible alpha-amylase inhibitory effects in vitro. Phytotherapy Research, 20(3), 228–231. https://doi.org/https://doi.org/10.1002/ptr.1839
- Lauria, A., Ippolito, M., & Almerico, A. M. (2009). Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors. Computational Biology and Chemistry, 33(5), 386–390. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2009.07.010
- Leeson, P. (2012). Drug discovery: Chemical beauty contest. Nature, 481(7382), 455–456. https://doi.org/https://doi.org/10.1038/481455a
- Lin, Y., Shi, R., Wang, X., & Shen, H. M. (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Current Cancer Drug Targets, 8(7), 634–646. https://doi.org/https://doi.org/10.2174/156800908786241050
- Liu, L., Li, Y., & Sun, C. (2015). The metabolic change of serum dehydroepiandrosterone sulfate, free fatty acids and desaturase activity in isolated post-challenge hyperglycemia. Journal of Stem Cell Research and Therpy, 5, 291.
- Liu, Y., Yu, S., Wang, F., Yu, H., Li, X., Dong, W., Lin, R., & Liu, Q. (2018). Chronic administration of ellagic acid improved the cognition in middle-aged overweight men. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme, 43(3), 266–273. https://doi.org/https://doi.org/10.1139/apnm-2017-0583
- Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., Alvarado, M., Anderson, H. R., Anderson, L. M., Andrews, K. G., Atkinson, C., Baddour, L. M., Barker-Collo, S., Bartels, D. H., Bell, M. L., … Memish, Z. A. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380(9859), 2095–2128. https://doi.org/https://doi.org/10.1016/S0140-6736(12)61728-0
- Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442. https://doi.org/https://doi.org/10.1371/journal.pmed.0030442
- Mogasale, V., Maskery, B., Ochiai, R. L., Lee, J. S., Mogasale, V. V., Ramani, E., Kim, Y. E., Park, J. K., & Wierzba, T. F. (2014). Burden of typhoid fever in low-income and middle-income countries: A systematic, literature-based update with risk-factor adjustment. The Lancet. Global Health, 2(10), e570–e580. https://doi.org/https://doi.org/10.1016/S2214-109X(14)70301-8
- Nakano, T., Inoue, I., Seo, M., Takahashi, S., Komoda, T., & Katayama, S. (2009). Acarbose attenuates postprandial hyperlipidemia: Investigation in an intestinal absortive cell model. Metabolism, 58(5), 583–585. https://doi.org/https://doi.org/10.1016/j.metabol.2009.02.003
- Nickavar, B., Abolhasani, L., & Izadpanah, H. (2008). Alpha amylase inhibitory activities of six Salvia species. Iranian Journal of Pharmaceutical Research, 7, 297–303.
- Nieman, D. C., Henson, D. A., Davis, J. M., Dumke, C. L., Gross, S. J., Jenkins, D. P., Murphy, E. A., Carmichael, M. D., Quindry, J. C., McAnulty, S. R., McAnulty, L. S., Utter, A. C., & Mayer, E. P. (2007). Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States Endurance Run. Journal of Interferon & Cytokine Research, 27(12), 1003–1011. https://doi.org/https://doi.org/10.1089/jir.2007.0050
- Nisha, C., Kumar, A., Vimal, A., Bai, B., Pal, D., & Kumar, A. (2016). Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor. Journal of Molecular Graphics & Modelling, 65, 100–107. https://doi.org/https://doi.org/10.1016/j.jmgm.2016.03.001
- O'Boyle, N., Banck, M., James, C., Morley, C., Vandermeersch, T., & Hutchison, G. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33. https://doi.org/https://doi.org/10.1186/1758-2946-3-33
- Oboh, G., Ogunsuyi, O. B., Ogunbadejo, M. D., & Adefegha, S. A. (2016). Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose. Journal of Food and Drug Analysis, 24(3), 627–634. https://doi.org/https://doi.org/10.1016/j.jfda.2016.03.003
- Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England), 29(7), 845–854. https://doi.org/https://doi.org/10.1093/bioinformatics/btt055
- Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/https://doi.org/10.1016/j.diabres.2019.107843
- Saha, S., & Verma, R. (2012). Inhibitory potential of traditional herbs on α-amylase activity. Pharmaceutical Biology, 50(3), 326–331. https://doi.org/https://doi.org/10.3109/13880209.2011.608075
- Sompong, W., & Adisakwattana, S. (2015). Inhibitory effect of herbal medicines and their trapping abilities against methylglyoxal-derived advanced glycation end-products. BMC Complementary and Alternative Medicine, 15(1), 394. https://doi.org/https://doi.org/10.1186/s12906-015-0897-8
- Sudha, P., Zinjarde, S. S., Bhargava, S. Y., & Kumar, A. R. (2011). Potent alpha-amylase inhibitory activity of Indian ayurvedic medicinal plants. BMC Complementary and Alternative Medicine, 11(1), 5. https://doi.org/https://doi.org/10.1186/1472-6882-11-5
- Tamil, I. G., Dineshkumar, B., Nandhakumar, M., Senthilkumar, M., & Mitra, A. (2010). In vitro study on alpha-amylase inhibitory activity of an Indian medicinal plant, Phyllanthus amarus. Indian Journal of Pharmacology, 42(5), 280–282.
- Trott, O., & Olson, A. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
- Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/https://doi.org/10.1002/jcc.21367
- Wallace, A., Laskowski, R., & Thornton, J. (1995). LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, 8(2), 127–134. https://doi.org/https://doi.org/10.1093/protein/8.2.127
- Wang, H., Du, Z., Zhang, C., Tang, Z., He, Y., Zhang, Q., Zhao, J., & Zheng, X. (2014). Biological evaluation and 3D-QSAR studies of curcumin analogues as aldehyde dehydrogenase 1 inhibitors. International Journal of Molecular Sciences, 15(5), 8795–8807. https://doi.org/https://doi.org/10.3390/ijms15058795
- WHO. (2012). Top 10 leading causes of death in the world 2000 and 2012. Retrieved May, 2014, from http://www.who.int/mediacentre/factsheets/fs310/en/.